Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Children's PediaCare Long-Acting Cough Plus Cold
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Children's PediaCare Long-Acting Cough Plus Cold is an over-the-counter (OTC) combination medication specifically formulated for pediatric use to treat symptoms of the common cold, flu, and other respiratory conditions. It contains dextromethorphan, a non-opioid cough suppressant that acts on the cough center in the brain to elevate the cough threshold, and a nasal decongestant such as phenylephrine or pseudoephedrine, which works by constricting blood vessels in the nasal passages to reduce swelling and congestion. Developed by Pfizer Consumer Healthcare and now marketed by Haleon, the product is designed to provide symptom relief for up to 6 to 8 hours. It is available in child-friendly formats, including grape-flavored liquids and chewable tablets, and is marketed as an alcohol-free, non-drowsy option for children's cold and cough management.
- Brand names
- Children's PediaCare Long-Acting Cough Plus ColdPediaCare Long-Acting Cough Plus Cold
02
Targets
HRH1 (Histamine H1 Receptor)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1A (α1A)NMDAR (Glutamate receptor ionotropic, NMDA)Nicotinic Acetylcholine Receptor
Beyond the preview
Go deeper on Children's PediaCare Long-Acting Cough Plus Cold.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Children's PediaCare Long-Acting Cough Plus Cold.